异常早孕期筛查分析物患者循环母体胎盘生长因子水平与超声评估的比较
这项回顾性队列研究纳入2017至2020年间早孕期生物标志物异常的单胎妊娠,比较中孕期母体循环胎盘生长因子(PlGF)水平正常与偏低(低于相应孕周第10百分位)者的超声所见、母胎结局及胎盘病理。71例中35例(49.3%)PlGF偏低;偏低组胎儿生长受限、早产型子痫前期、34周前早产及母体血管灌注不良胎盘病理均更多见,校正子宫动脉多普勒与胎儿生物测量后关联仍显著。作者认为中孕期PlGF在识别 destined to develop placental dysfunction 的患者亚组方面优于全面超声评估,或可作为替代的初始 approaches,尤其在专科可及性受地域限制时。
要点
- 早孕期筛查分析物异常的单胎妊娠中,49.3%(35/71)中孕期PlGF低于孕周第10百分位。
- PlGF偏低组胎儿生长受限(估重<第3百分位)42.9% vs 8.3%,早产型子痫前期22.9% vs 0%,34周前早产54.3% vs 8.3%。
- PlGF偏低组母体血管灌注不良胎盘病理72.7% vs 21.7%,校正子宫动脉多普勒与胎儿生物测量后关联仍显著。
核心结论
- 在早孕期生物标志物异常且原因不明的妊娠中,中孕期PlGF在识别 destined to develop placental dysfunction 的患者亚组方面优于全面超声评估。
- 作者认为该血液检测在此情境下或可作为替代的初始 approaches,尤其在专科可及性受地域限制时。
研究设计与样本
- 回顾性队列研究,纳入2017至2020年间早孕期生物标志物异常的单胎妊娠,排除染色体或结构异常妊娠。
- 所有患者均行超声检查(含子宫动脉多普勒)并检测母体循环PlGF,比较PlGF正常与偏低(低于相应孕周第10百分位)组的超声所见、母胎结局及胎盘病理。
主要发现
- 共评估71例妊娠,其中35例(49.3%)PlGF偏低。
- 与PlGF正常组相比,PlGF偏低组胎儿生长受限(估重<第3百分位)发生率42.9% vs 8.3%(p=0.001)。
- 与PlGF正常组相比,PlGF偏低组早产型子痫前期发生率22.9% vs 0%(p=0.002)。
- 与PlGF正常组相比,PlGF偏低组34周前早产发生率54.3% vs 8.3%(p<0.001)。
- 与PlGF正常组相比,PlGF偏低组母体血管灌注不良胎盘病理发生率72.7% vs 21.7%(p<0.001)。
关键数值与推荐
- PlGF偏低定义为低于相应孕周第10百分位。
- 胎儿生长受限定义为估重<第3百分位。
- 校正子宫动脉多普勒与胎儿生物测量状态后,中孕期PlGF偏低仍与上述胎盘介导并发症显著相关。
- PlGF的预测能力优于超声影像,超声信息与PlGF状态联合时诊断改善幅度很小。
临床怎么用
- 作者认为在早孕期生物标志物异常且原因不明的妊娠中,中孕期PlGF或可作为替代的初始 approaches,尤其在专科可及性受地域限制时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role of mid-trimester placental growth factor (PlGF) in patients with abnormal circulating levels of first-trimester biomarkers. METHODS: Retrospective cohort study including singleton pregnancies complicated by abnormal first-trimester biomarkers (2017-2020). Pregnancies complicated with chromosomal/structural anomalies were excluded. All patients had ultrasound imaging including uterine artery Doppler combined with measurement of maternal circulating PlGF. Sonographic findings, maternal and perinatal outcomes, and placental histopathology were compared between pregnancies with normal and low (<10th percentile for gestational age) PlGF levels. The diagnostic accuracy of PlGF for the prediction of specific placental-mediated complications was compared with the uterine artery Doppler assessment and additional sonographic findings. RESULTS: Seventy-one pregnancies were assessed, of which 35 (49.3%) had low PlGF levels. Maternal sociodemographic characteristics, nulliparity, and aspirin consumption were comparable. In comparison with patients with normal PlGF levels, individuals with low PlGF levels had a higher rate of fetal growth restriction (EFW <3rd centile; 42.9% vs. 8.3%, p = 0.001), preterm-preeclampsia (22.9% vs. 0%, p = 0.002), preterm delivery <34 weeks (54.3% vs. 8.3%, p < 0.001) and maternal vascular malperfusion placental pathology (72.7% vs. 21.7%, p < 0.001) following delivery. Adjusting for uterine artery Doppler and fetal biometry status, mid-trimester low PlGF remained significantly associated with these placental-mediated complications. The predictive capacity of PlGF outperformed ultrasound imaging with only minimal diagnostic improvement when ultrasound information was combined with PlGF status. CONCLUSION: In pregnancies with unexplained abnormal first-trimester biomarkers, mid-trimester PlGF outperformed a comprehensive ultrasound assessment in the identification of a subset of patients destined to develop placental dysfunction. This blood test may be an alternative initial approach in this context, especially where access to specialist care is more geographically challenging.
引用
- Ashwal E, Keunen J, Ravichandran A, et al. Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes. Prenat Diagn. 2023. PMID: 36738445. doi:10.1002/pd.6327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。